Tech Company Inital Public Offerings
PTC Therapeutics IPO
PTC Therapeutics, based in South Plainfield, debuted as a public company on 6/20/2013.
Transaction Overview
Company Name
Announced On
6/20/2013
Transaction Type
IPO
Amount
$126,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
100 Corporate Ct.
South Plainfield, NJ 07080
USA
South Plainfield, NJ 07080
USA
Phone
Website
Email Address
Overview
PTC (NASDAQ; PTCT) is a biopharmaceutical company focused on the discovery, development, and commercialization of small-molecule drugs targeting post-transcriptional control mechanisms.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stuart Peltz
Chief Financial Officer
Christine Utter
Vice President
Mary Harmon
VP - General Counsel
Mark Boulding
VP - Human Resources
Martin Rexroad
VP - R & D
Neil Almstead
Browse more venture capital transactions:
Prev: 6/20/2013: Nano-Meta Technologies venture capital transaction
Next: 6/20/2013: Trigemina venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs